Living with Neuroendocrine Tumors
People with neuroendocrine tumors can lead meaningful, active, productive lives. Learn how you can make the most of every day.
The latest in NET News
Positive results from the Phase III NETTER-2 trial were reported in September. The NETTER-2 trial
A key tenet of NETRF’s mission is to help NET patients navigate the challenges of
We are very grateful to Buckeye Cable Arts Network for allowing us to promote and
Attend a NET patient conference
2Singh S, Granberg D, Wolin E, et al. Patient-reported burden of a neuroendocrine tumor (NET) diagnosis: results from the first global survey of patients with NETs. J Glob Oncol. 2016;2(1):43-53.